Переносимость и безопасность бенакорта у больных аспириновой бронхиальной астмой

In some patients with aspirin-induced asthma ingestion of aspirin and other non-steroid anti-inflammatory drugs is associated with development of severe bronchoconstriction. Similar symptoms may be induced in these patients by substances traditionally used as a preservative for the food industry and now as a carrier in some antiasthmatic dry powder inhalers (Benacort®, Russia, 1 dose: 200 mg of budesonide and 9,8 mg of sodium benzoate). The present study has assessed the safety of sodium benzoate in aspirin-induced asthma patients.